T. Rowe Price Investment Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-206,939
| Closed | -$1.54M | – | 671 |
|
|
2024
Q4 | $1.54M | Sell |
206,939
-1,061,815
| -84% | -$7.91M | ﹤0.01% | 594 |
|
|
2024
Q3 | $10.1M | Sell |
1,268,754
-802,809
| -39% | -$6.41M | 0.01% | 548 |
|
|
2024
Q2 | $18M | Buy |
2,071,563
+466,800
| +29% | +$4.06M | 0.01% | 509 |
|
|
2024
Q1 | $33.2M | Buy |
1,604,763
+46,088
| +3% | +$953K | 0.02% | 452 |
|
|
2023
Q4 | $36M | Buy |
+1,558,675
| New | +$36M | 0.02% | 433 |
|